# Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules in Bacterial Vaginosis

> **NCT07418957** · PHASE3 · COMPLETED · sponsor: **Guangdong Longchuangji Pharmaceutical Co., Ltd.** · enrollment: 402 (actual)

## Conditions studied

- Bacterial Vaginosis (BV)

## Interventions

- **DRUG:** Vaginal Lactobacillus Dual Probiotic Capsules
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07418957
- **Lead sponsor:** Guangdong Longchuangji Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-12
- **Primary completion:** 2025-05-17
- **Final completion:** 2025-07-03
- **Target enrollment:** 402 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07418957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07418957, "Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules in Bacterial Vaginosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07418957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*